Product Pipeline

Product Indication Target Status More Information
EG12014/EGI014
Trastuzumab Biosimilar
Cancer HER2 Phase III For more information click here
Her2 Family Products
EG1206A
Pertuzumab Biosimilar
Cancer HER2 Preclinical  
EG13074
New Formulation
Cancer HER2 Preclinical  
TSY0110(EG12043)
Antibody-Drug Conjugate
Cancer HER2 Preclinical  
EG12021
Bevacizumab Biosimilar
Cancer VEGF Preclinical  
EG74032
CRM197 Carrier Protein
- Carrier protein for conjugate vaccines GMP manufacturing  
EG62054
Biosimilar
Undisclosed Undisclosed Preclinical